top of page


We are looking for people living with HIV who have been undetectable

for at least 2 years to evaluate the safety and effectiveness of a new experimental HIV therapeutic vaccine and to see if it helps control HIV. 

5369 blast.png
5369 1.png

About this Study



This investigational study seeks to evaluate the safety and effectiveness of a new HIV vaccine. This vaccine is not meant to prevent HIV infection, but rather to improve how the immune system of HIV+ people responds to the virus. And so, we call this a therapeutic or treatment vaccine.

Participants will be randomized (like flipping a coin) to receive at  entry, 1 month, 3 months & 6 months one of the following:

     A.  A new HIV therapeutic vaccine (meant not to prevent HIV infection, but rather boost your body’s immune response), plus a booster shot with a traditional vaccine

     B.  Just the traditional vaccine alone

     C.  A placebo

5369 logo.png


  • On stable HIV treatment for a minimum of 2 years

  • Undetectable HIV viral load

  • CD4+ greater than 500

  • Lowest CD4 count ever of 350

  • Cannot have a cardiac pacemaker, automatic implantable cardiac defibrillator, nerve stimulators, or deep brain stimulator

  • No current Hepatitis B or C infection

  • No history of seizures or irregular heart rhythm

  • No large tattoos over the upper arm

  • No diabetes

  • Weigh more than 110 and less than 440 pounds

  • For women of reproductive potential - not planning pregnancy or pregnant

  • No auto-immune diseases

  • No history of cancer requiring chemotherapy in the past 5 years

  • No HIV related opportunistic infections in the past 5 years

  • Willing to have leukapheresis

Length of Study:  Approximately 48 weeks


Schedule of Study Appointments: Screening, Pre-Entry, Entry, Weeks 1, 4, 6, 12, 24, 26 and 48


Medications administered during study:  Vaccine (4 doses) or placebo vaccine


Study Procedures:  Medical histories, Physical exams, Blood draws, Questionnaires, Vaccines, 2 optional leukapheresis procedures


Reimbursement:  $20 per visit starting at Pre-Entry for non-vaccine visits, $25 per visit for each of the 4 vaccine visits, and $250 for each of the 2 leukapheresis procedures


Contact:  ACTU Screening Nurse at either 206-744-8883 (phone) or 206-733-7129 (text)

5369 2.png
5369 cure related.png
therapuetic vaccine.jpg
bottom of page